Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Translational Identification of Medication Repurposing Candidates to Slow Cognitive Decline in Dementia

NCT05817188 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT05817188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05817188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Translational Identification of Medication Repurposing Candidates to Slow Cognitive Decline in Dementia
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Completed
Start date
January 1, 2023
Completion date
March 1, 2025
Enrollment
100,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer dementia, dementia disorders